Roche CoaguChek PT market withdrawal
This article was originally published in The Gray Sheet
Class I recall notice Sept. 26 cites possible corruption caused by misalignment of "easy-open" notches on prothrombin test strip packaging during manufacturing. Users of the test alerted Roche of the problem, and on Sept. 12 the firm asked patients to discard lots 591 and 619. Users are encouraged to "inspect each pouch prior to use...and run two strips each time they test" to ensure accuracy of all other lots. The firm will replace damaged packaging and maintains that the problem is corrected. A similar issue among European lots led to a UK recall Sept. 9...
You may also be interested in...
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.